AI-generated summary
The authors compared light-activated chlorophyll derivative photodynamic therapy with methotrexate chemotherapy in MCF-7 breast cancer cells in vitro. They report that 50% tumour cell death was reached at a chlorophyll derivative concentration 138 times lower than methotrexate, and that the chlorophyll derivative caused no genetic side effects in normal lymphocytes, unlike methotrexate. These are laboratory cell findings only.
- Who or what was studied
- MCF-7 breast cancer cell line and normal human peripheral blood lymphocytes (in vitro)
- Limits stated in the abstract
- The study was performed in vitro on cultured cells, so the findings do not establish effects in patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.